Generic drug industry lawsuit blasts Maryland pricing law as 'unconstitutional and invalid'

Fierce Pharma ------- With a generic drug pricing law set to take effect this fall in Maryland, the industry is pushing back hard with a lawsuit that says the regulation will “wreak untold disruptions” on the pharma industry nationally. In a suit (PDF) filed Thursday, the generic industry’s lobby group is asking for an injunction against the state’s HB 631, arguing that the regulation is overly vague, that it affects commerce outside of the state and that it stands to harm the public. Passed last month, Maryland’s pricing law will outlaw “unconscionable” price hikes in the generic industry and gives the state’s attorney general Brian Frosh the power to ask companies to explain their drastic price increases. If he determines there’s been a violation of the law, Frosh could then ask a court to force drug companies to roll back their price hikes and pay up to $10,000 for each violation. To learn more click on the picture below to read the article.